STRENGTH-DURATION CURVE - A MEASURE FOR ASSESSING SENSORY DEFICIT IN PERIPHERAL NEUROPATHY

被引：19
|
作者：
FRIEDLI, WG [1 ]
MEYER, M [1 ]
机构：
[1] UNIV HOSP ZURICH,DEPT NEUROL,CH-8091 ZURICH,SWITZERLAND
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 1984年 / 47卷 / 02期
关键词：
D O I：
10.1136/jnnp.47.2.184
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：184 / 189
页数：6
相关论文
共 42 条
  • [41] Assessing gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): study protocol for a randomized controlled clinical trial
    Teran-Wodzinski, Patricia
    Haladay, Douglas
    Vu, Tuan
    Ji, Ming
    Coury, Jillian
    Adams, Alana
    Schwab, Lauren
    Visovsky, Constance
    TRIALS, 2022, 23 (01)
  • [42] Randomized double blind (DB) placebo (Plcb) controlled phase III study assessing the efficacy of xaliproden (X) in reducing the cumulative peripheral sensory neuropathy (PSN) induced by the oxaliplatin (Ox) and 5-FU/LV combination (FOLFOX4) in first-line treatment of patients (pts) with metastatic colorectal cancer (MCRC).
    Cassidy, J.
    Bjarnason, G. A.
    Hickish, T.
    Topham, C.
    Provencio, M.
    Bodoky, G.
    Landherr, L.
    Koralewski, P.
    Lopez-Vivanco, G.
    Said, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 147S - 147S
12345